David Engelthaler Archives

DxNA and TGen submit Valley Fever test for FDA approval

DxNA LLC, a molecular diagnostics company, today announced the 510(k) submission to the U.S. Food and Drug Administration (FDA) of its molecular diagnostics assay using its proprietary GeneSTAT System and GeneSTAT Coccidiodes molecular test for rapid detection of Coccidiomycosis (Valley Fever). The Valley Fever assay on the GeneSTAT System, upon clearance by the FDA, provides for… Read More →

TGen study finds origin of lung fungus

Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global “public health vigilance,” according to a study by an international team led by the Translational Genomics Research Institute (TGen). C. gattii, which likely originated in Brazil, is responsible for dozens of deaths in recent years since it was… Read More →